Latest news on access to COVID-19 treatments

This page sets out which COVID-19 treatments are currently available on the NHS and how to access them.

Overview: access to COVID-19 treatments in the UK

Our policy team explain the most recent updates on treatments for COVID-19 and what they mean for you.

COVID-19 update, where we are today and what is in place to help protect me this winter?

The aim of this webinar is to inform leukaemia patients and their families on COVID-19 recommendations and available strategies to aid navigating during the coming winter.

Where: At home

“I caught COVID-19 and I’m a former ALL patient” Advice and support available

In this blog, our Advocacy Officer and former ALL patient, Sophie, discusses her recent experience with testing positive for COVID-19 and accessing antiviral medications. We know that this process doesn’t always run smoothly, so Sophie not only explains how the process should typically work, but also what to do when something goes wrong, and how she can help other patients who are in this situation.

The latest on Evusheld, a COVID-19 preventative treatment

In this blog we explain what we know about the preventative COVID-19 treatment, Evusheld, and answer some of the most common questions we have received from patients.

What are my options now to help protect me from COVID-19?

The overall aim of this webinar is to update patients on the current COVID-19 vaccination and treatment guidance.

Where: Online via Zoom and Facebook Live

Changes to COVID-19 testing after 6th November 2023

New changes to the process of accessing free lateral flow tests for immunocompromised people have been announced. This blog will outline what you need to know.

Leukaemia Care’s COVID-19 Statement

Our policy team brings you up to speed on our latest response to COVID-19 and how we are sharing the impact it has had on patients with decision makers.

COVID-19 and leukaemia; what more do we know?

This webinar will explore the latest guidance and recommendations for leukaemia patients, including those who are immunocompromised and the clinically extremely vulnerable. Are there different recommendations for different groups of patients?

Where: At home

Latest on the COVID-19 spring booster

This article provides information on the latest COVID-19 booster programme.